PcMab-47: Novel Antihuman Podocalyxin Monoclonal Antibody for Immunohistochemistry. - Wikidata - wikimedia - TriplyDB

PcMab-47: Novel Antihuman Podocalyxin Monoclonal Antibody for Immunohistochemistry.

PcMab-47: Novel Antihuman Podocalyxin Monoclonal Antibody for Immunohistochemistry.

http://www.wikidata.org/entity/Q33600992

about

Anti-podocalyxin antibody exerts antitumor effects via antibody-dependent cellular cytotoxicity in mouse xenograft models of oral squamous cell carcinoma.Determination of critical epitope of PcMab-47 against human podocalyxin.Podocalyxin is crucial for the growth of oral squamous cell carcinoma cell line HSC-2

P2860

Q55249763-81244D2C-C3E6-43AD-90E1-4E1CDF8E1888 Q55316843-D61E5D63-B4AA-49B9-99AA-5BD49EC08433 Q58797407-CFC870B2-B2AE-4DF4-8835-BDCE518FCD93

P2860

PcMab-47: Novel Antihuman Podocalyxin Monoclonal Antibody for Immunohistochemistry.

http://www.wikidata.org/entity/Q33600992

description

2017 nî lūn-bûn

@nan

2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

name

PcMab-47: Novel Antihuman Podocalyxin Monoclonal Antibody for Immunohistochemistry.

@ast

PcMab-47: Novel Antihuman Podocalyxin Monoclonal Antibody for Immunohistochemistry.

@en

type

label

PcMab-47: Novel Antihuman Podocalyxin Monoclonal Antibody for Immunohistochemistry.

@ast

PcMab-47: Novel Antihuman Podocalyxin Monoclonal Antibody for Immunohistochemistry.

@en

prefLabel

PcMab-47: Novel Antihuman Podocalyxin Monoclonal Antibody for Immunohistochemistry.

@ast

PcMab-47: Novel Antihuman Podocalyxin Monoclonal Antibody for Immunohistochemistry.

@en

P1433

Q33600992-43D1BFA5-0EDF-43E6-8B2B-7F43F3A34C40

P1476

Q33600992-C8A2C4A0-397B-4938-AA34-89A87493D5A0

P2093

Q33600992-04DE08AE-70EE-4735-B178-84B5908DF067

Q33600992-0B8EEDAB-00A8-45EA-BCB1-F51003A86B9B

Q33600992-31AC765E-373C-4CDA-AA5E-7B4DC7E74CC5

Q33600992-443DF1C0-8950-4551-A85D-3B9723C5BF75

Q33600992-4B7BC87A-EC3F-4E4F-A0E1-4E97E2033A2A

Q33600992-5F7DFE37-EE5A-4404-9818-A07CFBEC2DB9

Q33600992-9CF058D5-8030-466E-9961-70108243D084

Q33600992-BA059F88-F310-4386-B170-56619FA456B2

Q33600992-D4E9377A-055E-4678-9796-E48EEA14B837

P2860

Q33600992-017085ED-C26E-4AD0-9131-6187523F7DE8

Q33600992-01AB85AF-9FC9-4B6E-8545-8079567B98E4

Q33600992-036C96E2-AE8D-4583-8DFA-77D6054808D3

Q33600992-056CE474-3A10-4FF5-8A70-1AD26DE306DE

Q33600992-0C4AD947-7810-4A23-A731-3D2DF0E562CC

Q33600992-144064E0-DCD9-4924-9C14-B70485200A32

Q33600992-17F3AF79-84D4-4CEF-97D5-F82166E08B90

Q33600992-1DF94A85-72B4-4A22-8582-43DB7BE269B0

Q33600992-22067606-8ECD-4907-B888-A1C471159628

Q33600992-223E305B-0B33-4405-95FA-6112D1632437

P304

Q33600992-496DCA81-DEEC-4F3C-893F-B8403563E8DE

P31

Q33600992-BDDDFEDC-DFEC-4F80-B4A5-8050AF4A97DA

P356

Q33600992-39873600-B578-40A5-9D2F-175C9524D281

P433

Q33600992-847CC01B-32EF-41CA-95C0-E4B64EBA30BA

P478

Q33600992-F08D6B1A-266C-40FD-BB37-64305F867B68

P50

Q33600992-63E3D8E9-BA8F-4468-B759-CFED7E42CD1D

P577

Q33600992-C8C3BA41-7962-4D99-BDAF-B67B4CE49358

P698

Q33600992-B1611655-A3E8-4E71-A5CC-7684DBA3E690

P921

Q33600992-DF6777E4-6F7B-4D48-91A2-9B58D6B47460

P932

Q33600992-8B6DDB10-3A9A-494D-9D57-53D47C882645

P356

P1433

Monoclonal Antibodies in Immunodiagnosis and Immunotherapy

P1476

PcMab-47: Novel Antihuman Podocalyxin Monoclonal Antibody for Immunohistochemistry

@en

P2093

Kanae Yoshida

http://www.w3.org/2001/XMLSchema#string

Mika K Kaneko

http://www.w3.org/2001/XMLSchema#string

Miyuki Yanaka

http://www.w3.org/2001/XMLSchema#string

Noriko Saidoh

http://www.w3.org/2001/XMLSchema#string

Ryusuke Honma

http://www.w3.org/2001/XMLSchema#string

Satoshi Ogasawara

http://www.w3.org/2001/XMLSchema#string

Shinji Yamada

http://www.w3.org/2001/XMLSchema#string

Takuro Nakamura

http://www.w3.org/2001/XMLSchema#string

Yuki Fujii

http://www.w3.org/2001/XMLSchema#string

P2860

Podocalyxin enhances breast tumor growth and metastasis and is a target for monoclonal antibody therapy

Podocalyxin EBP50 ezrin molecular complex enhances the metastatic potential of renal cell carcinoma through recruiting Rac1 guanine nucleotide exchange factor ARHGEF7

Expression of podocalyxin enhances the adherence, migration, and intercellular communication of cells

Molecular cloning and characterization of human podocalyxin-like protein. Orthologous relationship to rabbit PCLP1 and rat podocalyxin

Loss of glomerular foot processes is associated with uncoupling of podocalyxin from the actin cytoskeleton

Podocalyxin-like protein is an E-/L-selectin ligand on colon carcinoma cells: comparative biochemical properties of selectin ligands in host and tumor cells

Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin

Thrombomucin, a novel cell surface protein that defines thrombocytes and multipotent hematopoietic progenitors

The cell surface mucin podocalyxin regulates collective breast tumor budding.

Human embryonal carcinoma tumor antigen, Gp200/GCTM-2, is podocalyxin

P304

50-56

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/MAB.2017.0008

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-04-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28384052

http://www.w3.org/2001/XMLSchema#string

P921

immunohistochemistry

P932

5404275

http://www.w3.org/2001/XMLSchema#string